GATA3 antigen
- Known as:
- GATA3 antigenic
- Catalog number:
- 'H00002625-Q02
- Product Quantity:
- 10
- Category:
- -
- Supplier:
- ACR
- Gene target:
- GATA3 antigen
Related genes to: GATA3 antigen
- Gene:
- GATA3 NIH gene
- Name:
- GATA binding protein 3
- Previous symbol:
- -
- Synonyms:
- HDR
- Chromosome:
- 10p14
- Locus Type:
- gene with protein product
- Date approved:
- 1992-11-03
- Date modifiied:
- 2016-10-05
Related products to: GATA3 antigen
'F 4_80 Antigen (mouse) Host Rat'F 4_80 Antigen (mouse) Host Rat(Anti_Tg)Thyroglobulin Antigen(Des-Asp187)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
(Des-Asp187)-ME20M_ME20S (185-193) (human, bovine, mouse), (Des-Asp187)-Melanocyte Lineage-Specific Antigen GP100 (185-193) (hu(Des-Asp187,Met186)-Melanocyte Protein PMEL 17 (185-193) (human, bovine, mouse)
(Des-Asp187,Met186)-Melanoma-Associated ME20 Antigen (185-193) (human, bovine, mouse), (Des-Asp187,Met186)-95 kDa Melano(Des_Asp187,Met186)_Melanocyte Protein PMEL 17 (185_193) (human, bovine, mouse) Salt Trifluoroacetate Binding _ Synonym (Des_Asp187,Met186)_Melanoma_Associated ME20 Antigen (185_193) (human, bovine(Des_Asp187,Met186)_Melanocyte Protein PMEL 17 (185_193) (human, bovine, mouse) Salt Trifluoroacetate Binding _ Synonym (Des_Asp187,Met186)_Melanoma_Associated ME20 Antigen (185_193) (human, bovine(Des_Asp187,Met186)_Melanocyte Protein PMEL 17 (185_193) (human, bovine, mouse) Salt Trifluoroacetate Binding _ Synonym (Des_Asp187,Met186)_Melanoma_Associated ME20 Antigen (185_193) (human, bovine(Des_Asp187,Met186)_Melanocyte Protein PMEL 17 (185_193) (human, bovine, mouse) Salt Trifluoroacetate Binding _ Synonym (Des_Asp187,Met186)_Melanoma_Associated ME20 Antigen (185_193) (human, bovine(Draxin) C1ORf187, Antigen blocking peptide(Val438)-Tyrosinase (432-444) (human)
(Val438)-LB24-AB (432-444) (human), (Val438)-Monophenol Monooxygenase (432-444) (human), (Val438)-SK29-AB (432-444) (human), (Val438)-Tumor Rejection Antigen AB (0x19 Antigen0x2 Antigen1,25-dihydroxyvitamin D3 Competitive ELISA, Coated with Antigen105 kDa islet cell antigen,BEM-3,Brain-enriched membrane-associated protein tyrosine phosphatase,ICA105,PTP IA-2,PTPLP,Ptprn,Rat,Rattus norvegicus,Receptor-type tyrosine-protein phosphatase-like N,R-P Related articles to: GATA3 antigen
- Current therapies for diabetic kidney disease (DKD) targeting hyperglycemia and hypertension fail to halt progression, urging exploration of additional drivers. Renal lipotoxicity and chronic inflammation form a self-perpetuating cycle driving DKD, yet multitarget interventions remain underexplored. We hypothesized that simultaneous inhibition of ANGPTL3 and IL-33, two key regulators of lipid metabolism and the inflammatory-fibrotic axis, would ameliorate DKD, and that integrating both antagonistic activities into a single bifunctional molecule offers translational advantages. We engineered a bifunctional fusion protein, FD03-sST2, comprising an anti-ANGPTL3 nanobody fused to the IL-33 decoy receptor sST2. In high-fat diet-fed db/db mice, FD03-sST2 significantly improved renal function (ACR, BUN, urine volume), reduced serum/hepatic lipids, and attenuated renal lipid accumulation. Mechanistically, it suppressed renal inflammation via NF-κB/NLRP3 inhibition and ameliorated fibrosis by suppressing the IL-33/ST2/ILC2 axis (reducing renal IL-33/GATA3 signals and inhibiting IL-33-induced profibrotic factors from ILC2s). Transcriptomic and metabolomic analyses confirmed attenuation of DKD-associated dysregulation. This study identifies a DKD cascade wherein lipotoxicity triggers IL-33 release, amplifying injury through inflammation and fibrosis. By targeting ANGPTL3 and IL-33 simultaneously, FD03-sST2 interrupts this vicious cycle at two nodes-improving lipid metabolism while suppressing downstream inflammatory and fibrotic signaling-providing an integrated alternative to separate biologics. - Source: PubMed
Publication date: 2026/05/19
Li ZhuojinCao ZhonglianZhou RongruiCheng XuHu XiaozhiXu ShuwenDou ZihanDu LingJu Dianwen - Secretory breast carcinoma (SBC) is an extremely rare subtype, accounting for ~1% of breast cancers but representing the most common malignant breast tumor in pediatric patients. Although generally indolent, SBC carries a risk of local recurrence even decades after treatment. Its defining molecular hallmark is the ETV6-NTRK3 fusion. - Source: PubMed
Publication date: 2026/05/14
Vlahović ANikolić SDjuričić S MDunđerović DIlić NSarajlija ADenčić Fekete MCvetinović AVasić M - Aberrant activation of , a key oncogenic driver, defines a major subgroup comprising ∼30% of childhood T-lineage acute lymphoblastic leukemias (T-ALLs). We and others have shown that somatic non-coding mutations within upstream and intronic -regulatory regions of contribute to transformation by creating binding sites for MYB and other transcription factors. Here we investigated -regulatory mechanisms mediated by somatic mutations occurring in an intergenic region located 29 kilobase pairs downstream of the canonical transcription initiation site, implicated in 6% of -expressing T-ALLs. These somatic variants include i) complex indels resulting in MYB transcription factor binding sites (TFBSs) and ii) internal tandem duplications (ITDs) encompassing canonical MYB TFBSs. Chromatin immunoprecipitation sequencing (ChIP-seq) revealed binding of the TAL1 core regulatory circuit (CRC) transcription factors MYB, GATA3, and RUNX1, resulting in enhancer activity mediated by sequences with the mutant allele. Strikingly, ChIP-seq peaks for the repressive H3K27me3 mark and the active H3K27ac mark co-existed across regulatory sequences but enriched for different haplotypes. transcription from the mutant haplotype initiated from a promoter located within exon 4 of the canonical transcript, resulting in a short isoform normally expressed by hematopoietic stem cells (HSC). Interestingly, neither the isoform expression nor the enhancer activity could be predicted by the sequence-to-function deep learning artificial intelligence (AI) model AlphaGenome, emphasizing the importance of experimental validation. Our findings indicate that selection for -regulatory, non-coding variants leads to reactivation of enhancers normally active in HSC but silenced in differentiated lineages during normal hematopoietic cell development. - Source: PubMed
Publication date: 2026/05/06
Terekhanova Nadezhda VChen XiaolongChow Kin-HoeLiu YuShao YingDong LiJu BenshengVinayachandran VineshZubair HaseebHagiwara KoheiYang WentaoMa XiaotuNatarajan SivaramanEaston JohnTeachey David TLook A ThomasZhang Jinghui - Colonic immune homeostasis is critically maintained by regulatory T (Treg) cells. Here, we identify SUMO-specific peptidase 1 (SENP1) as an important regulator of colonic Treg function and intestinal immune homeostasis. Treg-specific Senp1 deletion does not impair thymic Treg development, but selectively disrupts the homeostasis of colonic Treg subset without affecting Treg maintenance in other peripheral tissues. Mechanistically, SENP1 deficiency reduces CD25 expression on Tregs, blunting IL-2 responsiveness and compromising their expansion and survival. This is associated with a selective reduction in the proportion of tissue-adapted Gata3 Tregs and accumulation of CD25 precursor-like Tregs in the intestinal lamina propria. Senp1 depletion also downregulates core effector Treg signature genes including Gata3, Klrg1, and Il1rl1, correlating with dysregulated Th2 response control. Single-cell RNA sequencing analysis reveals transcriptional alterations consistent with impaired colonic Treg tissue adaptation after SENP1 ablation. Functionally, with adoptive transfer experiments we found that Senp1-deficient Tregs show impaired accumulation in vivo and are associated with weaker control of pathogenic T cell expansion in the colon. Consistently, Treg-specific Senp1-deficient mice display heightened susceptibility to DSS-induced colitis, highlighting a critical role of SENP1 in sustaining functional Treg programs and limiting pathogenic intestinal inflammation. - Source: PubMed
Publication date: 2026/05/16
Hao YanyunLiu HongzhiLiang QiuliFan QiujuWang TianshiCheng Jinke - Gastric cancer (GC) remains a major global health burden, often diagnosed at advanced stages with poor prognosis. Helicobacter pylori (H. pylori) infection promotes GC development through inflammation and altered signaling. Collagen triple helix repeat containing 1 (CTHRC1), a secreted ECM protein, is upregulated in several cancers and may be involved in H. pylori-related gastric tumorigenesis, though the mechanism is unclear. - Source: PubMed
Publication date: 2026/05/17
Ma MengdiZhang ChaoyangYu KexunWang HuizhenLi Yongxiang